Stay updated on Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.

Latest updates to the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page
- Check6 days agoChange DetectedThe page history shows an addition of Revision: v3.3.1 and deletion of Revision: v3.2.0, which appear to be internal revision log updates rather than user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoChange DetectedNotice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew version entries with updated submission dates and changes were added to the Record History, extending the list of recorded updates.SummaryDifference0.0%

- Check49 days agoChange Detected- The recruitment status has shifted from 'Active, not recruiting' and an older date to new terms indicating termination and new strategic context, with updated dates (2025-10-01, 2025-10-06) and a consolidated study status entry.SummaryDifference1%

- Check56 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference7%

- Check64 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.2%

Stay in the know with updates to Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.